Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 9.56
+0.01 (0.10%)
Sep 4, 2026, 5:07 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 115.89 million as of September 4, 2026. Its market cap has increased by 18.80% in one year.
Market Cap
115.89M
Enterprise Value
123.50M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.56
ChartMarket Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 115.89M, an increase of 3,597.76%. That is a compound annual growth rate of 23.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 115.89M | 12.80% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 313.83M |
| PureTech Health | 293.08M |
| Bioventix | 90.39M |
| 4basebio | 73.81M |
| Faron Pharmaceuticals Oy | 72.43M |
| Poolbeg Pharma | 62.91M |
| Ondine Biomedical | 59.75M |
| Sareum Holdings | 48.50M |